Evidence map›Paper›PMID 26192919›Full record

SynthesisNature genetics2015

Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.

Jimmy Z Liu, Suzanne van Sommeren, Hailiang Huang, Siew C Ng, Rudi Alberts, Atsushi Takahashi, Stephan Ripke, James C Lee, Luke Jostins, Tejas Shah and 32 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,533 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,533citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,533 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. iScience · 2026
    Article
  19. Article
  20. Genetic architectures of brain-related traits are shaped by strong selective constraints.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article

1,473 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Jimmy Z Liu *Wellcome Trust Sanger Institute, Hinxton, UK.
Suzanne van Sommeren *Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Hailiang HuangAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Siew C NgDepartment of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
Rudi AlbertsDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
Atsushi TakahashiLaboratory for Statistical Analysis, Center for Integrative Medical Sciences, Riken, Yokohama, Japan.
Stephan RipkeAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
James C LeeInflammatory Bowel Disease Research Group, Addenbrooke's Hospital, Cambridge, UK.
Luke JostinsWellcome Trust Centre for Human Genetics, University of Oxford, Headington, UK.
Tejas ShahWellcome Trust Sanger Institute, Hinxton, UK.
Shifteh AbedianDigestive Disease Research Institute, Shariati Hospital, Tehran, Iran.
Jae Hee CheonYonsei University College of Medicine, Seoul, Korea.
Judy ChoIcahn School of Medicine, Mount Sinai New York, New York, USA.
Naser E DayaniDepartment of Gastroenterology, Emam Hospital, Tehran, Iran.
Lude FrankeDepartment of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Yuta FuyunoLaboratory for Genotyping Development, Center for Integrative Medical Sciences, Riken, Yokohama, Japan.
Ailsa HartIBD Unit, St Mark's Hospital, Harrow, Middlesex, UK.
Ramesh C JuyalNational Institute of Immunology, Aruna Asaf Ali Road, New Delhi, India.
Garima JuyalDepartment of Genetics, University of Delhi South Campus, New Delhi, India.
Won Ho KimYonsei University College of Medicine, Seoul, Korea.
Andrew P MorrisWelcome Trust Center for Human Genetics, Oxford U.K. and Department of Biostatistics, University of Liverpool, Liverpool, UK.
Hossein PoustchiDigestive Disease Research Institute, Shariati Hospital, Tehran, Iran.
William G NewmanManchester Centre for Genomic Medicine, University of Manchester and Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Vandana MidhaDepartment of Medicine, Dayanand Medical College and Hospital, Ludhiana, India.
Timothy R OrchardSt Mary's Hospital, London, UK.
Homayon VahediDigestive Disease Research Institute, Shariati Hospital, Tehran, Iran.
Ajit SoodDepartment of Medicine, Dayanand Medical College and Hospital, Ludhiana, India.
Joseph Y SungDepartment of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong.
Reza MalekzadehDigestive Disease Research Institute, Shariati Hospital, Tehran, Iran.
Harm-Jan WestraDepartment of Genetics, University Medical Center Groningen, Groningen, The Netherlands.
Keiko YamazakiLaboratory for Genotyping Development, Center for Integrative Medical Sciences, Riken, Yokohama, Japan.
Suk-Kyun YangAsan Medical Center, University of Ulsan College Medicine, Seoul, Korea.
International Multiple Sclerosis Genetics Consortium
International IBD Genetics Consortium
Jeffrey C BarrettWellcome Trust Sanger Institute, Hinxton, UK.
Behrooz Z AlizadehDepartment of Epidemiology, University Medical Center Groningen, Groningen, The Netherlands.
Miles ParkesInflammatory Bowel Disease Research Group, Addenbrooke's Hospital, Cambridge, UK.
Thelma BkDepartment of Genetics, University of Delhi South Campus, New Delhi, India.
Mark J DalyAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Michiaki KuboLaboratory for Genotyping Development, Center for Integrative Medical Sciences, Riken, Yokohama, Japan.
Carl A AndersonWellcome Trust Sanger Institute, Hinxton, UK.
Rinse K WeersmaDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Inflammatory Bowel Disease Genetics Consortium Data Coordinating CenterU01DK062429 · NIDDK · YALE UNIVERSITY · PI CHO, JUDY H. · 2002 to 2016
$16.8M
A Haplotype Map for Multiple SclerosisR01NS049477 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAUSER, STEPHEN L · 2005 to 2014
$15.3M
NIDDK IBD Genetics Consortium Genetic Research CenterU01DK062420 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2002 to 2021
$7.8M
Impact of Genetic Variability on Cellular Pathways and Host-Microbiome InteractioU01DK062423 · NIDDK · SINAI HEALTH SYSTEM · PI MARK S. SILVERBERG · 2002 to 2026
$7.5M
Chief Scientist Office ETM/137Chief Scientist Office ETM/75Department of Health NIHR-RP-R3-12-026Medical Research Council G0600329Medical Research Council G0800675Medical Research Council G0800759MRF_ C0482NIDDK NIH HHS P30 DK043351NIDDK NIH HHS U01 DK062420NIDDK NIH HHS U01 DK062423NIDDK NIH HHS U01 DK062429NINDS NIH HHS R01 NS049477Wellcome Trust 098017Wellcome Trust 098051Wellcome Trust 102974
6 · The paper itself

Abstract

Ulcerative colitis and Crohn's disease are the two main forms of inflammatory bowel disease (IBD). Here we report the first trans-ancestry association study of IBD, with genome-wide or Immunochip genotype data from an extended cohort of 86,640 European individuals and Immunochip data from 9,846 individuals of East Asian, Indian or Iranian descent. We implicate 38 loci in IBD risk for the first time. For the majority of the IBD risk loci, the direction and magnitude of effect are consistent in European and non-European cohorts. Nevertheless, we observe genetic heterogeneity between divergent populations at several established risk loci driven by differences in allele frequency (NOD2) or effect size (TNFSF15 and ATG16L1) or a combination of these factors (IL23R and IRGM). Our results provide biological insights into the pathogenesis of IBD and demonstrate the usefulness of trans-ancestry association studies for mapping loci associated with complex diseases and understanding genetic architecture across diverse populations.

Indexed as

Case-Control StudiesColitis, UlcerativeCrohn DiseaseGene FrequencyGenetic LociGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID26192919
PMCPMC4881818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.